prof. Filip Van den Bosch
work address
De Pintelaan 185, 0K12-IB
9000 Gent
9000 Gent
ORCID iD
https://orcid.org/0000-0002-3561-5932
1 – 10 of 116
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2018
- Effect of mechanical stress on magnetic resonance imaging of the sacroiliac joints: assessment of military recruits by magnetic resonance imaging study
- Prevalence of comorbidities and risk factors for comorbidities in patients with spondyloarthritis in Latin America : a comparative study with the general population and data from the ASAS-COMOSPA study
- Immunoscintigraphic detection of tumour necrosis factor by radiolabelled certolizumab pegol in patients with erosive hand osteoarthritis : a proof-of-concept study
- 2017
- Response to: 'Clinical benefit of vedolizumab on articular manifestations in patients with active spondyloarthritis associated with inflammatory bowel disease' by Orlando et al
- Presence of bone marrow edema and structural lesions on magnetic resonance imaging of the sacroiliac joints in young military recruits before and after 6 weeks of intensive physical training
- Presence of bone marrow edema on magnetic resonance imaging of the sacroiliac joints in military recruits before and after 6 weeks of intensive physical training
- Prevalence of structural lesions typical for axial spondyloarthritis in young military recruits before and after mechanical stress
- Secukinumab in active rheumatoid arthritis after anti-TNFα therapy : a randomized, double-blind placebo-controlled phase 3 study
- Sustained efficacy, safety and patient-reported outcomes of certolizumab pegol in axial spondyloarthritis : 4-year outcomes from RAPID-axSpA
- Effects of long-term etanercept treatment on clinical outcomes and objective signs of inflammation in early nonradiographic axial spondyloarthritis : 104-week results from a randomized, placebo-controlled study